Penetration of Moxifloxacin Into Liver Tissue of Patients Undergoing Liver Resection.

NCT01302951 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Side-effect of Antibiotic

Interventions

DRUG: Moxifloxacin 400 mg

Sponsor

University Hospital, Saarland

Collaborators

[object Object]